Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA [Yahoo! Finance Canada]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance Canada
Hims & Hers ( HIMS ) is launching a new GLP-1 tracker in its efforts to fight back against the FDA's decision to end compounded GLP-1s on the market. The tracker allows patients to self-identify, provide their location, and say which brand of GLP-1 drug they are not able to find. The data will be aggregated and regularly published by Hims in order to provide proof to the FDA that the shortages of the branded drugs haven't ended, according to co-founder and CEO Andrew Dudum. "We shared, as of a week ago, north of 80,000 people on our platform ... are not able to get access to these medicines and [are] reporting shortage. And that's really only accelerating. Last week, we had more than 2,000 people in one day," Dudum told Yahoo Finance in an exclusive interview. "The reality on the ground is that it's a very widespread shortage," he said. The move comes after the FDA took tirzepatide, the key ingredient in Eli Lilly's ( LLY ) diabetes drug Mounjaro and weight-loss drug Zepbound
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- New Alzheimer's prevention trial receives $74.5 million NIH grant [Yahoo! Finance]Yahoo! Finance
- 2 Top Growth Stocks to Buy on the Dip [Yahoo! Finance]Yahoo! Finance
- Lung Cancer Therapy Research Report 2024: Demand for Targeted Therapy, Arrival of Nanomedicine, Emergence of New Diagnostics and Advanced Therapies, Growth of Combination Therapy - Forecasts to 2029 [Yahoo! Finance]Yahoo! Finance
- 3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years [Yahoo! Finance]Yahoo! Finance
- Lilly expands R&D footprint in Singapore with SGD$42 million investment in new Digital Health Innovation Hub [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/24 - Miss
LLY
Sec Filings
- 11/8/24 - Form 144
- 11/8/24 - Form 4
- 11/5/24 - Form 4
- LLY's page on the SEC website